Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma

C. Robert, J. J. Grob, D. Stroyakovskiy, B. Karaszewska, A. Hauschild, E. Levchenko, V. Chiarion Sileni, J. Schachter, C. Garbe, I. Bondarenko, H. Gogas, M. Mandalá, J. B.A.G. Haanen, C. Lebbé, A. MacKiewicz, P. Rutkowski, P. D. Nathan, A. Ribas, M. A. Davies, K. T. FlahertyP. Burgess, M. Tan, E. Gasal, M. Voi, D. Schadendorf, G. V. Long

    Research output: Contribution to journalArticlepeer-review

    847 Scopus citations

    Fingerprint

    Dive into the research topics of 'Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences